News
Detailed price information for Royalty Pharma Plc Cl A (RPRX-Q) from The Globe and Mail including charting and trades.
Flutter Entertainment (FLTR) upped full-year guidance after a solid second quarter, with group revenue up 16 per cent to $4.2bn (£3.1bn) and adjusted Ebitda climbing 25 per cent to $919mn. Average ...
GSK provides update on US settlement of CureVac/BioNTech mRNA patent litigation: London, UK Saturday, August 9, 2025, 10:00 Hrs [IST] GSK plc announces that, in connection with th ...
Donald Trump’s plan to force down drug prices in the United States by demanding pharmaceutical companies raise prices in countries like the ...
With a 5.98% market share, India is the fourth-largest pharmaceutical supplier to the U.S., behind Ireland, Switzerland, and ...
This week in Other Barks & Bites: the USPTO terminates 52,000 trademark applications and registrations via sanctions; the ...
The tussle had centred on the development of mRNA jab technology, which was at the forefront of the fight against Covid-19.
GSK is set to receive up to $500 million and 1% royalties on future vaccine sales following the settlement of a US patent dispute between CureVac NV, Pfizer, and BioNTech SE.
GSK said it will receive $370 million as part of the U.S. patent settlement involving CureVac and BioNTech over mRNA-based COVID-19 vaccines, The Wall Street Journal reported Aug. 8. Under the deal, ...
Shares of behavioral health company LifeStance Health (NASDAQ:LFST) jumped 11% in the afternoon session after the company ...
Donald Trump’s tariffs have dragged markets on a merry dance for much of this year. Goods being shipped into the US are now subject to levies of up to 39 per cent and a new front targeting ...
The settlement ends US mRNA patent disputes involving COVID-19 and influenza vaccines, while positioning GSK for additional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results